Search by Drug Name or NDC
NDC 00074-4378-05 Nimbex 2 mg/mL Details
Nimbex 2 mg/mL
Nimbex is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AbbVie Inc.. The primary component is CISATRACURIUM BESYLATE.
Product Information
| NDC | 00074-4378 |
|---|---|
| Product ID | 0074-4378_8b56347b-c00b-40d9-a41a-c926e4b1c357 |
| Associated GPIs | 74200013102014 |
| GCN Sequence Number | 024614 |
| GCN Sequence Number Description | cisatracurium besylate VIAL 2 MG/ML INTRAVEN |
| HIC3 | S7A |
| HIC3 Description | NEUROMUSCULAR BLOCKING AGENTS |
| GCN | 32771 |
| HICL Sequence Number | 010278 |
| HICL Sequence Number Description | CISATRACURIUM BESYLATE |
| Brand/Generic | Brand |
| Proprietary Name | Nimbex |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Cisatracurium besylate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 2 |
| Active Ingredient Units | mg/mL |
| Substance Name | CISATRACURIUM BESYLATE |
| Labeler Name | AbbVie Inc. |
| Pharmaceutical Class | Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA020551 |
| Listing Certified Through | 2023-12-31 |
Package
NDC 00074-4378-05 (00074437805)
| NDC Package Code | 0074-4378-05 |
|---|---|
| Billing NDC | 00074437805 |
| Package | 5 mL in 1 VIAL, SINGLE-DOSE (0074-4378-05) |
| Marketing Start Date | 2010-12-09 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |